SS-31

Phase 3 Clinical Trials (Barth Syndrome)

Also known as: Elamipretide, Bendavia, MTP-131

Longevity / Anti-AgingSubcutaneousIntravenous

A mitochondria-targeted tetrapeptide that concentrates 1000x in the inner mitochondrial membrane. Restores bioenergetics and reduces oxidative damage.

Molecular Weight640.8 Da
Half-Life (t½)~4 hours
SequenceD-Arg-Dmt-Lys-Phe-NH2

Mechanism of Action

Selectively binds cardiolipin on the inner mitochondrial membrane, stabilizing electron transport chain complexes, reducing ROS production, and optimizing ATP synthesis.

Dosing Protocol

0.25 mg/kg/hr IV infusion or 40mg subcutaneous daily in clinical trials.

Open peptide calculator

Reconstitution

Research-grade: typically supplied in solution.

Storage

Refrigerate 2-8°C. Protect from light.

Side Effects

  • Injection site reactions
  • Headache
  • Generally well-tolerated in trials

Key Research Findings

  • Improved cardiac function in Barth Syndrome patients (Phase 3)
  • Reversed age-related mitochondrial dysfunction in preclinical models
  • Improved exercise tolerance in heart failure trials

Latest Verified Lab Report

No lab reports available for SS-31 yet.

Community-funded testing results will appear here.

Vendor Trust Leaderboard

For SS-31

Trust leaderboard coming soon.

Vendor rankings based on verified lab test results.

Active Deals

APR Health Solutions
15% OFF
A

15% off with code at checkout.

TheResearchStop
Shop Vendor
Ameano Peptides
10% OFF
A

10% off with code at checkout.

theresearchstop
Shop Vendor
Puratek Peptides
10% OFF
Puratek Peptides

10% off — discount applied automatically via referral link.

Mile High Compounds
10% OFF
M

10% off with code at checkout.

theresearchstop
Shop Vendor
Advertisement

Sponsored Ad Space

Advertise with us

Research Use Only

This information is provided for educational and research purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional before using any research compounds.